Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

374
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
374
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

692
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
692
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor Lysis Syndrome Risk in Burkitt Lymphoma Versus Mantle Cell Lymphoma During Alkylating Therapy: A Propensity-Matched TriNetX Comparative Outcome Analysis.

Cureus·2026
Same author

Investigating the risk of non-alcoholic fatty liver disease in young patients with psoriasis versus non-psoriatic inflammatory skin diseases.

Scientific reports·2026
Same author

Does the term "non-compliant" bias physician perceptions? a preliminary inquiry into a single internal medicine residency training program.

Internal and emergency medicine·2026
Same author

New-Onset Atrial Fibrillation as an Early Marker of Anthracycline-Associated Cardiotoxicity and Mortality: A Retrospective Study.

Cureus·2026
Same author

Navigating luminal heterogeneity: etiology-based proteogenomic subtyping for targeted treatment strategies in breast cancer.

Molecular cancer·2026
Same author

The Role of Videoconferencing Teleconsultation in Improving Transfer Efficiency and Functional Outcomes in Rural Stroke Care: Retrospective Cohort Study.

JMIR mHealth and uHealth·2026

Related Experiment Video

Updated: Sep 11, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K

Virtual Diabetes "Boot Camp": An Innovative Model for Improving Glycemic Control.

Yi-Ju Chen1, Renu Joshi1, Anas Atrash1

  • 1From the Department of Internal Medicine, UPMC Central Pa., Harrisburg, PA (YJC, AA); Department of Family Medicine, Telehealth UPMC Central Pa., Harrisburg, PA (SMS, SK); Department of Endocrinology, UPMC Central Pa., Harrisburg, PA, USA (RJ).

Journal of the American Board of Family Medicine : JABFM
|August 11, 2025
PubMed
Summary

A 12-week telemedicine diabetes program significantly improved glycemic control (A1C) in patients with uncontrolled diabetes. Higher initial A1C levels correlated with greater reductions, demonstrating telemedicine

Keywords:
Diabetes MellitusElectronic Health RecordsGlycemic ControlPatient EducationPrimary Health CareTelemedicine

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.0K
An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

10.7K

Related Experiment Videos

Last Updated: Sep 11, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.0K
An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

10.7K

Area of Science:

  • Endocrinology
  • Digital Health
  • Primary Care Medicine

Background:

  • Telemedicine enhances patient-physician access and outcomes, particularly for chronic disease management.
  • The COVID-19 pandemic accelerated telemedicine adoption, expanding its application in healthcare.
  • An institution launched a 12-week telemedicine diabetes "boot camp" for uncontrolled diabetes patients.

Purpose of the Study:

  • To evaluate the effectiveness of a telemedicine-based diabetes intervention program.
  • To assess improvements in glycemic control and other health metrics in patients with poorly controlled diabetes.

Main Methods:

  • Voluntary enrollment of 134 patients with diabetes mellitus (DM) and A1C > 8.0% from Sept 2020 to Nov 2021.
  • Biweekly telemedicine visits conducted by dietitians and diabetes care specialists over 12 weeks.
  • Measurement of demographics, A1C, BMI, and blood pressure pre- and post-intervention.

Main Results:

  • A mean A1C reduction of -2.09% ± 2.4% was observed across all participants.
  • A1C reduction was consistent across various demographics and clinic types.
  • Higher initial A1C levels showed a negative correlation with A1C change, indicating greater improvement.

Conclusions:

  • The telemedicine diabetes program effectively improved A1C in patients with poorly controlled diabetes.
  • Intervention benefits were observed irrespective of patient characteristics.
  • Initial glycemic severity was a predictor of greater A1C reduction.